Rekvina Laboratories Ltd.

BSE: 526075

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

25.27-1.3 (-5.00%)

24 Jul, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Rekvina Laboratories Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	—
Quarterly Results	—	—	—	—	—	—	—	—	—	—	—	—	Mar Sept Dec	Mar
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Rekvina Laboratories Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201815 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg 74(5) of SEBI (DP) Regulation 2018
Open Offer - Updates30 Jun 2026
Announcement under Regulation 30 (LODR)-Open Offer - Updates
Open Offer Update
General30 Jun 2026
Pre-Offer Advertisement & Corrigendum to Detailed Public Statement
Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Pre-Offer Advertisement in accordance with Regulation 18(7) of The Securities and Exchange ....
Closure of Trading Window30 Jun 2026
Closure of Trading Window
Closure of Trading Window
Open Offer25 Jun 2026
Updates on Open Offer
Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors in accordance with Regulation 26(7) ....
Open Offer - Updates25 Jun 2026
Announcement under Regulation 30 (LODR)-Open Offer - Updates
Newspaper Advertisement
Open Offer - Updates24 Jun 2026
Announcement under Regulation 30 (LODR)-Open Offer - Updates
Recommendations of the Committee of Independent Directors of Company under Regulation 26(7) of SEBI (SAST) Regulation, 2011
Open Offer - Updates23 Jun 2026
Announcement under Regulation 30 (LODR)-Open Offer - Updates
We wish to inform you that the company has received a copy of the letter of offer issued by Vivro Financial Services Private Limited in relation to open offer to the Public Shareholders.
General23 Jun 2026
Letter of Offer
Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Letter of Offer for the attention of the Equity Shareholders of Rekvina Laboratories Ltd ("''Target ....
Outcome of Board Meeting21 May 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On 21St May, 2026
Pursuant to Reg 33 read with Part A of Schedule III of SEBI (LODR) Regulation, 2015, we hereby submitting the following: 1. Standalone Audited Financial Results for the Quarter ended ....
Board Meeting18 May 2026
Board Meeting Intimation for Consider And Approve Financial Result For The QTR 4
Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve Financial Result for the ....
EGM10 Apr 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Voting Results along with Scrutinizer Report
EGM10 Apr 2026
Shareholder Meeting / Postal Ballot-Outcome of EGM
Summary of Proceeding of EGM
Reg.24(A)-Annual Secretarial Compliance6 Apr 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
Non Applicability of Reg- 24(A) - Annual Secretarial Compliance Report
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20186 Apr 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018.
Open Offer - Updates2 Apr 2026
Announcement under Regulation 30 (LODR)-Open Offer - Updates
Update on Open Offer
General2 Apr 2026
Draft Letter of Offer
Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Draft Letter of Offer for the attention of the Equity Shareholders of Rekvina Laboratories ....
Open Offer - Updates24 Mar 2026
Announcement under Regulation 30 (LODR)-Open Offer - Updates
Update on Open Offer
General24 Mar 2026
Detailed Public Statement
Vivro Financial Services Pvt Ltd ("Manager to the Open Offer") has submitted to BSE a copy of Detailed Public Statement for the attention of the Equity Shareholders of Rekvina Laboratories ....
Closure of Trading Window24 Mar 2026
Closure of Trading Window
Trading window will remain closed with effect from, 1st April, 2026 until 48 hours after the declaration of Audited Financial Results by the Company for the Quarter & year ended on March 31, 2026.

Frequently Asked Questions

Where can I download the annual report of Rekvina Laboratories Ltd.?

Annual reports of Rekvina Laboratories Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Rekvina Laboratories Ltd.?

Quarterly earnings results and presentations of Rekvina Laboratories Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Rekvina Laboratories Ltd. publish earnings call transcripts?

Earnings call transcripts of Rekvina Laboratories Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Rekvina Laboratories Ltd.?

Investor presentations and annual day presentations of Rekvina Laboratories Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Rekvina Laboratories Ltd.?

Corporate announcements and regulatory filings of Rekvina Laboratories Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Rekvina Laboratories Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Rekvina Laboratories Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Rekvina Laboratories Ltd.?

The ISIN (International Securities Identification Number) of Rekvina Laboratories Ltd. is INE092O01028. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Rekvina Laboratories Ltd. listed?

Rekvina Laboratories Ltd. is listed on NSE and BSE. The NSE symbol is 526075-BOM and the BSE code is -.

Where can I find the shareholding pattern of Rekvina Laboratories Ltd.?

The quarterly shareholding pattern of Rekvina Laboratories Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Rekvina Laboratories Ltd. on Sharpely?

Share price data for Rekvina Laboratories Ltd. is updated as of 24 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.